Clinical Trial Update: A Study Comparing Amorphous Calcium Carbonate (ACC) Versus Crystalline Calcium CCS) in Hypoparathyroidism Patients [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial comparing amorphous calcium carbonate (ACC) to crystalline calcium carbonate in hypoparathyroidism has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoparathyroidism

Drugs mentioned

• Amorphous Calcium Carbonate (ACC) (amorphous calcium carbonate)
• Crystalline Calcium Carbonate (calcium carbonate)

Snippet

Sponsor: Amorphical Ltd. | Conditions: Hypoparathyroidism | Phase 1, Phase 2 | Status: COMPLETED